ITGB4 and leukemia: Two leukemia (UCSD/AML1 and MOLM1) and two primary human AML (PT9 and PT11) cells lines were cultured on matrigel and treated with or without anti-ITGA6, ITGB2, ITGB3, or ITGB4 antibodies.